Pin1 as an anticancer drug target

Drug News and Perspectives

Volumn 22, Issue 7, 2009, Pages 399-407

  Xu, Guoyan G ^a   Etzkorn, Felicia A ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 BENZOFURANONE DERIVATIVE; ACETIC ACID DERIVATIVE; ALKENE DERIVATIVE; ANTINEOPLASTIC AGENT; CYCLIN D1; DIETHYL 1,3,6,8 TETRAHYDRO 1,3,6,8 TETRAOXOBENZO[LMN][3,8]PHENANTHROLINE 2,7 DIACETATE; ISOMERASE INHIBITOR; JUGLONE; PEPTICINNAMIN E; PEPTIDOMIMETIC AGENT; PEPTIDYLPROLYL ISOMERASE PIN1; PERHYDROPYRROLIZINE DERIVATIVE; PHENANTHROLINE DERIVATIVE; PROTEIN C JUN; PROTEIN P53; PYRROLIZINE DERIVATIVE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BREAST CANCER; CARCINOGENESIS; COLORECTAL CANCER; DNA DAMAGE; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE OVEREXPRESSION; HUMAN; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; MOUTH CANCER; NONHUMAN; PROSTATE CANCER; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; THYROID TUMOR; UTERINE CERVIX CANCER;

ALZHEIMER DISEASE; ANIMALS; ANTINEOPLASTIC AGENTS; CELL CYCLE; DNA DAMAGE; HUMANS; NEOPLASMS; PEPTIDYLPROLYL ISOMERASE;

EID: 72449205615     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2009.22.7.1414594     Document Type: Review

References (72)

1. Lu, K.P., Hanes, S.D. and Hunter, T. A human peptidyl-prolyl isomerase essential for regulation of mitosis. Nature 1996, 380(6574): 544-7. (Pubitemid 26111332)
2. Joseph, J.D., Yeh, E.S., Swenson, K.I., Means, A.R. and Winkler, K.E. The peptidyl-prolyl isomerase Pin1. Prog Cell Cycle Res 2003, 5: 477-487
3. Yaffe, M.B., Schutkowski, M., Shen, M. et al. Sequence-specific and phosphorylation-dependent proline isomerization: a potential mitotic regulatory mechanism. Science 1997, 278(5345): 1957-1960 (Pubitemid 28013239)
4. Lu, K.P., Liou, Y.C. and Zhou, X.Z. Pinning down proline-directed phosphorylation signaling. Trends Cell Biol 2002, 12(4): 164-172
5. Ranganathan, R., Lu, K.P., Hunter, T. and Noel, J.P. Structural and functional analysis of the mitotic rotamase Pinl suggests substrate recognition is phosphorylation dependent. Cell 1997, 89(6): 875-886
6. Lu, K.P., Finn, G., Lee, T.H. and Nicholson, L.K. Prolyl cis-trans isomerization as a molecular timer. Nat Chem Biol 2007, 3(10): 619-629 (Pubitemid 47417709)
7. Fischer, G. Peptidyl-prolyl cis/trans isomerases and their effectors. Angew Chem, Int Ed Engl 1994, 33(14): 1415-1436 (Pubitemid 2113440)
8. Wiederrecht, G. and Etzkorn, F.A. The immunophilins. Perspect Drug Discov Design 1994, 2(1): 57-84.
9. Schroeder, O.E., Carper, E., Wind, J.J., Poutsma, J.L., Etzkorn, F.A. and Poutsma, J.C. Theoretical and experimental investigation of the energetics of cis-trans proline isomerization in peptide models. J Phys Chem A 2006, 110(20): 6522-6530 (Pubitemid 44020306)
10. Stukenberg, P.T. and Kirschner, M.W. Pin1 acts catalytically to promote a conformational change in Cdc25. Mol Cell 2001, 7(5): 1071-83.
11. Wulf, G.M., Liou, Y.C., Ryo, A., Lee, S.W. and Lu, K.P. Role of Pin1 in the regulation of p53 stability and p21 transactivation, and cell cycle checkpoints in response to DNA damage. J Biol Chem 2002, 277(50): 47976-47979 (Pubitemid 35470742)
12. Eckerdt, F., Yuan, J., Saxena, K. et al. Polo-like kinase 1-mediated phosphorylation stabilizes Pinl by inhibiting its ubiquitination in human cells. J Biol Chem 2005, 280(44): 36575-36583 (Pubitemid 41587733)
13. Zhou, X.Z., Kops, O., Werner, A. et al. Pin1-dependent prolyl isomerization regulates dephosphorylation of Cdc25C and tau proteins. Mol Cell 2000, 6(4): 873-883
14. Zhou, X.Z., Lu, P.J., Wulf, G. and Lu, K.P. Phosphorylation-dependent prolyl isomerization: a novel signaling regulatory mechanism. Cell Mol Life Sci 1999, 56(9-10): 788-806.
15. Shen, M., Stukenberg, P.T., Kirschner, M.W. and Lu, K.P. The essential mitotic peptidyl-prolyl isomerase Pin1 binds and regulates mitosis-specific phosphoproteins. Genes Dev 1998, 12(5): 706-720 (Pubitemid 28134302)
16. Xu, Y.X. and Manley, J.L. New insights into mitotic chromosome condensation: a role for the prolyl isomerase Pin1. Cell Cycle 2007, 6(23): 2896-2901
17. Xu, Y.X. and Manley, J.L. The prolyl isomerase Pin1 functions in mitotic chromosome condensation. Mol Cell 2007, 26(2): 287-300.
18. Bernis, C., Vigneron, S., Burgess, A. et al. Pin1 stabilizes Emi1 during G2 phase by preventing its association with SCF(betatrcp). EMBO Rep 2007, 8(1): 91-98 (Pubitemid 46043806)
19. Rippmann, J.F., Hobbie, S., Daiber, C. et al. Phosphorylation-dependent proline isomerization catalyzed by Pin1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ 2000, 11(7): 409-416 (Pubitemid 30619568)
20. Winkler, K.E., Swenson, K.I., Kornbluth, S. and Means, A.R. Requirement of the prolyl isomerase Pin1 for the replication checkpoint. Science 2000, 287(5458): 1644-1647 (Pubitemid 30127764)
21. Liou, Y.C., Ryo, A., Huang, H.K. et al. Loss of Pin1 function in the mouse causes phenotypes resembling cyclin D1-null phenotypes. Proc Natl Acad Sci U S A 2002, 99(3): 1335-1340 (Pubitemid 34136494)
22. Ryo, A., Liou, Y.C., Lu, K.P. and Wulf, G. Prolyl Isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. J Cell Sci 2003, 116(Pt 5): 773-783 (Pubitemid 36367627)
23. Wulf, G.M., Ryo, A., Wulf, G.C. et al. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1. Embo J 2001, 20(13): 3459-3472 (Pubitemid 32634353)
24. Monje, P., Hernandez-Losa, J., Lyons, R.J., Castellone, M.D. and Gutkind, J.S. Regulation of the transcriptional activity of c-Fos by ERK. A novel role for the prolyl isomerase Pin1. J Biol Chem 2005, 280(42): 35081-35084 (Pubitemid 41532693)
25. Zacchi, P., Gostissa, M., Uchida, T. et al. The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults. Nature 2002, 419(6909): 853-857 (Pubitemid 35238573)
26. Zheng, H., You, H., Zhou, X.Z. et al. The prolyl Isomerase Pin1 is a regulator of p53 in genotoxic response. Nature 2002, 419(6909): 849-53. (Pubitemid 35238572)
27. Mantovani, F., Piazza, S., Gostissa, M. et al. Pin1 Write the activities of c-Abl and p300 in regulating p73 function. Mol Cell 2004, 14(5): 625-636 (Pubitemid 38739084)
28. Yi, P., Wu, R.C., Sandquist, J. et al. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1). Mol Cell Biol 2005, 25(21): 9687-9699
29. Xu, Y.X. and Manley, J.L. Pinning down transcription: regulation of RNA polymerase II activity during the cell cycle. Cell Cycle 2004, 3(4): 432-435
30. De Nicola, F., Bruno, T., Iezzi, S. et al. The prolyl isomerase Pin1 affects Che-1 stability in response to apoptotic DNA damage. J Biol Chem 2007, 282(27): 19685-19691 (Pubitemid 47100057)
31. Berger, M., Stahl, N., Del Sal, G. and Haupt, Y. Mutations in proline 82 of p53 impair its activation by Pin1 and Chk2 in response to DNA damage. Mol Cell Biol 2005, 25(13): 5380-5388 (Pubitemid 40853575)
32. Honda, R., Tanaka, H. and Yasuda, H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 1997, 420(1): 25-27 (Pubitemid 28037193)
33. Bao, L., Kimzey, A., Sauter, G., Sowadski, J.M., Lu, K.P. and Wang, D.G. Prevalent overexpression of prolyl Isomerase Pin1 in human cancers. Am J Pathol 2004, 164(5): 1727-1737 (Pubitemid 38529775)
34. Atchison, F.W., Capel, B. and Means, A.R. Pin1 regulates the timing of mammalian primordial germ cell proliferation. Development 2003, 130(15): 3579-3586 (Pubitemid 37010020)
35. Kim, M.R., Choi, H.S., Heo, T.H., Hwang, S.W. and Kang, K.W. Induction of vascular endothelial growth factor by peptidyl-prolyl isomerase Pin1 in breast cancer cells. Biochem Biophys Res Commun 2008, 369(2): 547-553
36. Reineke, E.L., Lam, M., Liu, Q. et al. Degradation of the tumor suppressor PML by Pinl contributes to the cancer phenotype of breast cancer MDA-MB-231 cells. Mol Cell Biol 2008, 28(3): 997-1006. (Pubitemid 351160056)
37. Wulf, G., Garg, P., Liou, Y.C., Iglehart, D. and Lu, K.P. Modeling breast cancer in vivo and ex vivo reveals an essential role of Pin1 in tumorigenesis. Embo J 2004, 23(16): 3397-3407
38. Pang, R., Yuen, J., Yuen, M.F. et al. PIN1 overexpression and beta-catenin gene mutations are distinct oncogenic events in human hepatocellular carcinoma. Oncogene 2004, 23(23): 4182-4186 (Pubitemid 38747951)
39. Pang, R., Lee, T.K., Poon, R.T. et al. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007, 132(3): 1088-1103 (Pubitemid 46440863)
40. He, J., Zhou, F., Shao, K. et al. Overexpression of Pinl in non-small cell lung cancer (NSCLC) and its correlation with lymph node metas- tases. Lung Cancer 2007, 56(1): 51-58 (Pubitemid 46356645)
41. Fukuchi, M., Fukai, Y., Kimura, H. et al. Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol 2006, 29(2): 329-334
42. Li, H., Wang, S., Zhu, T. et al. Pin1 contributes to cervical tumorigenesis by regulating cyclin D1 expression. Oncol Rep 2006, 16(3): 491-496
43. Kuramochi, J., Arai, T., Ikeda, S., Kumagai, J., Uetake, H. and Sugihara, K. High Pin1 expression is associated with tumor progression in colorectal cancer. J Surg Oncol 2006, 94(2): 155-160 (Pubitemid 44267198)
44. Chen, S.Y., Wulf, G., Zhou, X.Z., Rubin, M.A., Lu, K.P. and Balk, S.P. Activation of beta-catenin signaling in prostate cancer by peptidyl-prolyl isomerase Pin1-mediated abrogation of the androgen receptor-beta-catenin interaction. Mol Cell Biol 2006, 26(3): 929-39. (Pubitemid 43146487)
45. Nakashima, M., Meirmanov, S., Naruke, Y. et al. Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression. J Pathol 2004, 202(4): 446-455 (Pubitemid 38456163)
46. Miyashita, H., Mori, S., Motegi, K., Fukumoto, M. and Uchida, T. Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. Oncol Rep 2003, 10(2): 455-461
47. Miyashita, H., Uchida, T., Mori, S., Echigo, S. and Motegi, K. Expression status of Pin1 and cyclins in oral squamous cell carcinoma: Pin1 correlates with Cyclin D1 mRNA expression and clinical significance of cyclins. Oncol Rep 2003, 10(4): 1045-1048
48. Lycan, D.E., Osley, M.A. and Hereford, L.M. Role of transcriptional and posttranscriptional regulation in expression of histone genes in Saccharomyces cerevisiae. Mol Cell Biol 1987, 7(2): 614-621
49. Liou, Y.C., Sun, A., Ryo, A. et al. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration. Nature 2003, 424(6948): 556-561 (Pubitemid 36975777)
50. Pastorino, L., Sun, A., Lu, P.J. et al. The prolyl isomerase Pin1 regulates amyloid precursor protein processing and amyloid-beta production. Nature 2006, 440(7083): 528-534
51. Akiyama, H., Shin, R.W., Uchida, C., Kitamoto, T. and Uchida, T. Pin1 promotes production of Alzheimer's amyloid beta from beta-cleaved amyloid precursor protein. Biochem Biophys Res Commun 2005, 336(2): 521-529 (Pubitemid 41267260)
52. Etzkorn, F.A. Pin1 flips Alzheimer's switch. ACS Chem Biol 2006, 1(4): 214-216
53. Zhang, Y., Fussel, S., Reimer, U., Schutkowski, M. and Fischer, G. Substrate-based design of reversible Pin1 inhibitors. Biochemistry 2002, 41(39): 11868-11877
54. Wildemann, D., Erdmann, F., Alvarez, B.H. et al. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries. J Med Chem 2006, 49(7): 2147-2150
55. Wang, X.J., Xu, B., Mullins, A.B., Neiler, F.K. and Etzkorn, F.A. Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere. J Am Chem Soc 2004, 126(47): 15533-15542 (Pubitemid 39577489)
56. Zhao, S. and Etzkorn, F.A. A phosphorylated prodrug for the inhibition of Pin1. Bioorg Med Chem Lett 2007, 17(23): 6615-6618
57. Xu, G.G. and Etzkorn, F.A. Design and synthesis of amine and ketone inhibitors of Pinl. 235th ACS Natl Meet (April 6-10, New Orleans) 2008: BIOL-057.
58. Daum, S., Erdmann, F., Fischer, G. et al. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1. Angew Chem Int Ed Engl 2006, 45(44): 7454-7458
59. Braun, M., Hessamian-Alinejad, A., Lacroix, B.F.d., Alvarez, B.H. and Fischer, G. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1 Molecules 2008, 13: 995-1003.
60. Siegrist, R., Zürcher, M., Baumgartner, C. et al. A novel synthesis of highly substituted perhydropyrrolizines, perhydroindolizines, and pyrrolidines: Inhibition of the peptidyl-prolyl cis/trans isomerase (PPIase) Pin1. Helv Chim Acta 2007, 90: 217-259 (Pubitemid 46931558)
61. Smet, C., Duckert, J.F., Wieruszeski, J.M. et al. Control of protein-protein interactions: structure-based discovery of low molecular weight inhibitors of the interactions between Pin1 WW domain and phosphopeptides. J Med Chem 2005, 48(15): 4815-5523 (Pubitemid 41033124)
62. Li, M., Stukenberg, P.T. and Brautigan, D.L. Binding of phosphatase inhibitor-2 to prolyl isomerase Pin1 modifies specificity for mitotic phosphoproteins. Biochemistry 2008, 47(1): 292-300.
63. Tung, H.Y., Wang, W. and Chan, C.S. Regulation of chromosome segregation by Glc8p, a structural homolog of mammalian inhibitor 2 that functions as both an activator and an inhibitor of yeast protein phosphatase 1. Mol Cell Biol 1995, 15(11): 6064-6074
64. Hennig, L., Christner, C., Kipping, M. et al. Selective inactivation of parvulin-like peptidyl-prolyl cis/trans isomeroses by juglone. Biochemistry 1998, 37(17): 5953-5960 (Pubitemid 28196748)
65. Chao, S.H., Greenleaf, A.L. and Price, D.H. Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription. Nucleic Acids Res 2001, 29(3): 767-773
66. Liu, J., Albers, M.W., Chen, C.M., Schreiber, S.L. and Walsh, C.T. Cloning, expression, and purification of human cyclophilin in Escherichia coli and assessment of the catalytic role of cysteines by site-directed mutagenesis. Proc Natl Acad Sci U S A 1990, 87(6): 2304-2308 (Pubitemid 20105305)
67. Uchida, T., Takamiya, M., Takahashi, M. et al. Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem Biol 2003, 10(1): 15-24. (Pubitemid 36154470)
68. Kesavapany, S., Patel, V., Zheng, Y.L. et al. Inhibition of Pin1 reduces glutamate-induced perikaryal accumulation of phosphorylated neurofilament-H in neurons. Mol Biol Cell 2007, 18(9): 3645-3655 (Pubitemid 47378701)
69. Bayer, E., Thutewohl, M., Christner, C. et al. Identification of hPin1 inhibitors that induce apoptosis in a mammalian Ras transformed cell line. Chem Commun (Camb) 2005, (4): 516-518 (Pubitemid 40187678)
70. Thutewohl, M., Kissau, L., Popkirova, B. et al. Identification of mono- and bisubstrate inhibitors of protein farnesyltransferase and inducers of apoptosis from a pepticinnamin E library. Bioorg Med Chem 2003, 11(12): 2617-26. (Pubitemid 36566622)
71. Lu, K.P. Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. Cancer Cell 2003, 4(3): 175-180 (Pubitemid 37163831)
72. Finn, G. and Lu, K.P. Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer. Curr Cancer Drug Targets 2008, 8(3): 223-229 (Pubitemid 351666858)